查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1599649

傷口生技藥品市場：按產品類型、傷口類型、最終用戶分類 - 2025-2030 年全球預測

Wound Biologics Market by Product (Biologic Skin Substitutes, Topical Agents), Wound Type (Burns, Surgical and Traumatic Wounds, Ulcers), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年傷口生技藥品市場價值為49.8億美元，預計到2024年將達到54.3億美元，複合年成長率為9.99%，預計到2030年將達到97億美元。

傷口生技藥品包括生長因子、皮膚替代品和膠原蛋白基質等產品，旨在透過利用生物成分來促進和增強癒合。這些產品可治療通常對常規治療有抵抗力的慢性和急性傷口，對於糖尿病患者和老年人等人至關重要。傷口生技藥品廣泛應用於醫院、診所和居家醫療機構，透過促進早期復健和最大限度地降低感染風險，在改善患者的生活品質方面發揮重要作用。市場動態主要由慢性傷口患者數量的增加、技術進步以及對微創手術的日益偏好所驅動。然而，市場擴張受到高產品成本、嚴格的監管要求和報銷挑戰的阻礙。由於醫療保健支出增加和對先進創傷護理解決方案認知的提高，新興國家尤其具有巨大的成長潛力。該市場還提供了個人化醫療領域的機會，其中生技藥品可以根據個別患者的需求進行客製化，並強調產品開發的創新。生技公司和研究機構之間的合作和夥伴關係可以進一步推動突破性治療方法並縮短時間。然而，公司必須克服激烈的競爭和不同的區域監管環境等限制。利用市場機會的策略建議包括投資於具有成本效益的生技藥品研究和開發，以及開發包含各種經過充分研究的生技藥品的產品系列，以應對不同的傷口類型，其中包括多樣化和擴展到開拓的市場。傷口生技藥品產業的本質是高度動態的，受到不斷創新和不斷變化的患者需求的驅動。

主要市場統計
基準年[2023] 49.8億美元
預測年份 [2024] 54.3億美元
預測年份 [2030] 97億美元
複合年成長率（%） 9.99%

市場動態：快速發展的傷口生技藥品市場的關鍵市場洞察

供需的動態交互作用正在改變傷口生技藥品市場。了解這些不斷變化的市場動態可以幫助企業做出明智的投資決策、策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助消費行為及其對製造業的影響。

  • 市場促進因素
    • 政府關於傷口護理的舉措
    • 燒燙傷和交通事故增加
    • 世界老年人口的增加
  • 市場限制因素
    • 傷口護理高成本
  • 市場機會
    • 創新傷口護理生技藥品簡介
    • 手術中對生物工程皮膚替代品的潛在需求
  • 市場挑戰
    • 缺乏訓練有素的醫生和污染相關的併發症

波特的五力：駕馭傷口生技藥品市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解傷口生技藥品市場的外部影響

外部宏觀環境因素在塑造傷口生技藥品市場的表現動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並幫助他們做出積極主動的決策。

市場佔有率分析 了解傷口生技藥品市場的競爭格局

對傷口生技藥品市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來發現自己的競爭定位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣生技藥品市場供應商的績效評估

FPNV定位矩陣是評估傷口生技藥品市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃傷口生技藥品市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對傷口生技藥品市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 政府關於傷口護理的舉措
      • 燒燙傷和交通事故發生率增加
      • 全球人口老化仍在持續
    • 抑制因素
      • 傷口治療費用高
    • 機會
      • 創新創傷護理生物製劑簡介
      • 手術中對生物工程皮膚替代品的潛在需求
    • 任務
      • 缺乏訓練有素的醫生和污染相關的併發症
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章傷口生技藥品市場：依產品

  • 生物皮膚替代品
    • 無細胞動物衍生產品
    • 生物合成產品
    • 人類供體組織衍生產品
  • 外用製劑

第7章依傷口類型分類的傷口生技藥品市場

  • 燒傷
  • 手術傷口及外傷傷口
  • 潰瘍
    • 糖尿病足潰瘍
    • 褥瘡
    • 靜脈潰瘍

第8章傷口生技藥品市場：依最終使用者分類

  • 門診手術中心
  • 燒燙傷中心
  • 醫院
  • 傷口診所

第9章美洲傷口生技藥品市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第10章亞太傷口生技藥品市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第11章歐洲、中東和非洲傷口生技藥品市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第12章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • 3M Company
  • Anika Therapeutics, Inc
  • Avita Medical, Inc.
  • B. Braun SE
  • Bioventus Inc.
  • Blaine Labs Inc.
  • ConvaTec Group PLC
  • Cytori Therapeutics Inc.
  • Fibroheal Woundcare Pvt Ltd
  • Integra Lifesciences Holdings Corporation
  • Kerecis hf
  • Marine Polymer Technologies, Inc.
  • MediWound Ltd.
  • Medline Industries, LP
  • Merakris Therapeutics, Inc.
  • MIMEDX GROUP, INC.
  • Molnlycke Health Care AB
  • Nuo Therapeutics, Inc.
  • Organogenesis Inc.
  • Polymedics Innovations GmbH
  • Royal Biologics, Inc.
  • Skye Biologics Holdings, LLC
  • Smith & Nephew PLC
  • Stability Biologics
  • Stryker Corporation
  • Surgilogix, LLC
  • Tides Medical
  • Vericel Corporation
  • Viatris Inc.
  • Vivex Biologics
Product Code: MRR-0315DDADCE4B

The Wound Biologics Market was valued at USD 4.98 billion in 2023, expected to reach USD 5.43 billion in 2024, and is projected to grow at a CAGR of 9.99%, to USD 9.70 billion by 2030.

Wound biologics, encompassing products like growth factors, skin substitutes, and collagen-based matrices, are designed to expedite and enhance healing by leveraging biological components. These products are critical, as they address chronic and acute wounds that are often resistant to traditional treatments, making them essential for populations such as diabetics or the elderly. Widely applied in hospitals, clinics, and home healthcare settings, wound biologics hold a significant role in improving patients' quality of life by promoting faster recovery and minimizing infection risks. The market dynamics are primarily propelled by an increase in chronic wound cases, technological advancements, and the growing preference for minimally invasive procedures. However, market expansion is hampered by high product costs, stringent regulatory requirements, and reimbursement challenges. Notably, emerging economies present significant growth potential due to increasing healthcare expenditure and a rising awareness of advanced wound care solutions. The market also offers opportunities in personalized medicine, where biologics can be tailored to individual patient needs, emphasizing innovation in product development. Collaborations and partnerships between biotechnological firms and research institutions can drive further advancements and reduce time-to-market for breakthrough treatments. Nonetheless, companies need to navigate constraints such as competitive intensity and variable regulatory landscapes across different regions. Strategic recommendations for tapping into market opportunities include investing in R&D for cost-effective biologics, diversifying product portfolios to include a range of well-researched biologics catering to different wound types, and expanding into underpenetrated markets. The nature of the wound biologics industry is highly dynamic, driven by continuous innovation and evolving patient demands, highlighting the necessity for businesses to remain agile and responsive to technological and regulatory changes.

KEY MARKET STATISTICS
Base Year [2023] USD 4.98 billion
Estimated Year [2024] USD 5.43 billion
Forecast Year [2030] USD 9.70 billion
CAGR (%) 9.99%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Wound Biologics Market

The Wound Biologics Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Government Initiatives Regarding Wound Care Treatment
    • Rising Incidences of Burn Injuries and Road Accidents
    • Increasing Geriatric Population Globally
  • Market Restraints
    • High Cost of Wound Treatment
  • Market Opportunities
    • Introduction of Innovative Wound Care Biologics
    • Potential Need for Bioengineered Skin Substitutes in Surgeries
  • Market Challenges
    • Lack of Trained Physicians and Complications Associated with the Contamination

Porter's Five Forces: A Strategic Tool for Navigating the Wound Biologics Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Wound Biologics Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Wound Biologics Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Wound Biologics Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Wound Biologics Market

A detailed market share analysis in the Wound Biologics Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Wound Biologics Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Wound Biologics Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Wound Biologics Market

A strategic analysis of the Wound Biologics Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Wound Biologics Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Anika Therapeutics, Inc, Avita Medical, Inc., B. Braun SE, Bioventus Inc., Blaine Labs Inc., ConvaTec Group PLC, Cytori Therapeutics Inc., Fibroheal Woundcare Pvt Ltd, Integra Lifesciences Holdings Corporation, Kerecis hf, Marine Polymer Technologies, Inc., MediWound Ltd., Medline Industries, LP, Merakris Therapeutics, Inc., MIMEDX GROUP, INC., Molnlycke Health Care AB, Nuo Therapeutics, Inc., Organogenesis Inc., Polymedics Innovations GmbH, Royal Biologics, Inc., Skye Biologics Holdings, LLC, Smith & Nephew PLC, Stability Biologics, Stryker Corporation, Surgilogix, LLC, Tides Medical, Vericel Corporation, Viatris Inc., and Vivex Biologics.

Market Segmentation & Coverage

This research report categorizes the Wound Biologics Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Biologic Skin Substitutes and Topical Agents. The Biologic Skin Substitutes is further studied across Acellular Animal-derived Products, Biosynthetic Products, and Human Donor Tissue-derived Products.
  • Based on Wound Type, market is studied across Burns, Surgical and Traumatic Wounds, and Ulcers. The Ulcers is further studied across Diabetic Foot Ulcers, Pressure Ulcers, and Venous Ulcers.
  • Based on End-User, market is studied across Ambulatory Surgery Centers, Burn Centers, Hospitals, and Wound Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Government Initiatives Regarding Wound Care Treatment
      • 5.1.1.2. Rising Incidences of Burn Injuries and Road Accidents
      • 5.1.1.3. Increasing Geriatric Population Globally
    • 5.1.2. Restraints
      • 5.1.2.1. High Cost of Wound Treatment
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of Innovative Wound Care Biologics
      • 5.1.3.2. Potential Need for Bioengineered Skin Substitutes in Surgeries
    • 5.1.4. Challenges
      • 5.1.4.1. Lack of Trained Physicians and Complications Associated with the Contamination
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Wound Biologics Market, by Product

  • 6.1. Introduction
  • 6.2. Biologic Skin Substitutes
    • 6.2.1. Acellular Animal-derived Products
    • 6.2.2. Biosynthetic Products
    • 6.2.3. Human Donor Tissue-derived Products
  • 6.3. Topical Agents

7. Wound Biologics Market, by Wound Type

  • 7.1. Introduction
  • 7.2. Burns
  • 7.3. Surgical and Traumatic Wounds
  • 7.4. Ulcers
    • 7.4.1. Diabetic Foot Ulcers
    • 7.4.2. Pressure Ulcers
    • 7.4.3. Venous Ulcers

8. Wound Biologics Market, by End-User

  • 8.1. Introduction
  • 8.2. Ambulatory Surgery Centers
  • 8.3. Burn Centers
  • 8.4. Hospitals
  • 8.5. Wound Clinics

9. Americas Wound Biologics Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Wound Biologics Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Wound Biologics Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Anika Therapeutics, Inc
  • 3. Avita Medical, Inc.
  • 4. B. Braun SE
  • 5. Bioventus Inc.
  • 6. Blaine Labs Inc.
  • 7. ConvaTec Group PLC
  • 8. Cytori Therapeutics Inc.
  • 9. Fibroheal Woundcare Pvt Ltd
  • 10. Integra Lifesciences Holdings Corporation
  • 11. Kerecis hf
  • 12. Marine Polymer Technologies, Inc.
  • 13. MediWound Ltd.
  • 14. Medline Industries, LP
  • 15. Merakris Therapeutics, Inc.
  • 16. MIMEDX GROUP, INC.
  • 17. Molnlycke Health Care AB
  • 18. Nuo Therapeutics, Inc.
  • 19. Organogenesis Inc.
  • 20. Polymedics Innovations GmbH
  • 21. Royal Biologics, Inc.
  • 22. Skye Biologics Holdings, LLC
  • 23. Smith & Nephew PLC
  • 24. Stability Biologics
  • 25. Stryker Corporation
  • 26. Surgilogix, LLC
  • 27. Tides Medical
  • 28. Vericel Corporation
  • 29. Viatris Inc.
  • 30. Vivex Biologics

LIST OF FIGURES

  • FIGURE 1. WOUND BIOLOGICS MARKET RESEARCH PROCESS
  • FIGURE 2. WOUND BIOLOGICS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL WOUND BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. WOUND BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. WOUND BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. WOUND BIOLOGICS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL WOUND BIOLOGICS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. WOUND BIOLOGICS MARKET DYNAMICS
  • TABLE 7. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY ACELLULAR ANIMAL-DERIVED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BIOSYNTHETIC PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY HUMAN DONOR TISSUE-DERIVED PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY TOPICAL AGENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BURNS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY SURGICAL AND TRAUMATIC WOUNDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY DIABETIC FOOT ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY PRESSURE ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY VENOUS ULCERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 23. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 24. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY BURN CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 25. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 26. GLOBAL WOUND BIOLOGICS MARKET SIZE, BY WOUND CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 28. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 29. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 31. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. AMERICAS WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 33. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 34. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 35. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 36. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 37. ARGENTINA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 40. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 42. BRAZIL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 43. CANADA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 44. CANADA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 45. CANADA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 46. CANADA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 47. CANADA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. MEXICO WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. MEXICO WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 50. MEXICO WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. MEXICO WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 52. MEXICO WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 53. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 54. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 55. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 57. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. UNITED STATES WOUND BIOLOGICS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 59. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 61. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 63. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. ASIA-PACIFIC WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 65. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 67. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 69. AUSTRALIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. CHINA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. CHINA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 72. CHINA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. CHINA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 74. CHINA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. INDIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. INDIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 77. INDIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. INDIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 79. INDIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 80. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 81. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 82. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 83. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 84. INDONESIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. JAPAN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. JAPAN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 87. JAPAN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. JAPAN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 89. JAPAN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 90. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 92. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 94. MALAYSIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 97. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 99. PHILIPPINES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 100. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 101. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 102. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 103. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 104. SINGAPORE WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 105. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 106. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 107. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 108. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 109. SOUTH KOREA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 111. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 112. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 113. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 114. TAIWAN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 115. THAILAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. THAILAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 117. THAILAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. THAILAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 119. THAILAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 120. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 121. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 122. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 123. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 124. VIETNAM WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 126. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 127. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 128. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 129. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 130. EUROPE, MIDDLE EAST & AFRICA WOUND BIOLOGICS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 131. DENMARK WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. DENMARK WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 133. DENMARK WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. DENMARK WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 135. DENMARK WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 136. EGYPT WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 137. EGYPT WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 138. EGYPT WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 139. EGYPT WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 140. EGYPT WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 141. FINLAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 142. FINLAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 143. FINLAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 144. FINLAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 145. FINLAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. FRANCE WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 147. FRANCE WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 148. FRANCE WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 149. FRANCE WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 150. FRANCE WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 151. GERMANY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. GERMANY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 153. GERMANY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. GERMANY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 155. GERMANY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 156. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 157. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 158. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 159. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 160. ISRAEL WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 161. ITALY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 162. ITALY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 163. ITALY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 164. ITALY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 165. ITALY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 166. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 167. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 168. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 169. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 170. NETHERLANDS WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 171. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 173. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 175. NIGERIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 176. NORWAY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 177. NORWAY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 178. NORWAY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 179. NORWAY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 180. NORWAY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 181. POLAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 182. POLAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 183. POLAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 184. POLAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 185. POLAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 186. QATAR WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 187. QATAR WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 188. QATAR WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 189. QATAR WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 190. QATAR WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 191. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 192. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 193. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 194. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 195. RUSSIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 196. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 197. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 198. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 199. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 200. SAUDI ARABIA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 201. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 202. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 203. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 204. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 205. SOUTH AFRICA WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 206. SPAIN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 207. SPAIN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 208. SPAIN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 209. SPAIN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 210. SPAIN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 211. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 212. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 213. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 214. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 215. SWEDEN WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 216. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 217. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 218. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 219. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 220. SWITZERLAND WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 221. TURKEY WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 222. TURKEY WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 223. TURKEY WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 224. TURKEY WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 225. TURKEY WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 226. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 227. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 228. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 229. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 230. UNITED ARAB EMIRATES WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 231. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 232. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY BIOLOGIC SKIN SUBSTITUTES, 2018-2030 (USD MILLION)
  • TABLE 233. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY WOUND TYPE, 2018-2030 (USD MILLION)
  • TABLE 234. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY ULCERS, 2018-2030 (USD MILLION)
  • TABLE 235. UNITED KINGDOM WOUND BIOLOGICS MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 236. WOUND BIOLOGICS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 237. WOUND BIOLOGICS MARKET, FPNV POSITIONING MATRIX, 2023